Skip to main content
SpringerLink
Log in

Prostatakarzinom

  • Chapter
Therapiekonzepte Onkologie

  • 56 Accesses

Zusammenfassung

Anatomisch werden innerhalb der Prostata die zentrale Zone, die Übergangszone und die periphere Zone unterschieden. Während sich das Prostataadenom durch ein Wachstum der Übergangszone entwickelt, haben die meisten Karzinome ihren Ursprung in der peripheren Zone.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ackermann R, Frohmüller HG (1983) Complications and morbidity following radical prostatectomy. World J Urol 1: 62–67

    Article  Google Scholar 

  2. Ackermann R, Müller H-A (1975) Retrospective analysis of 645 simultaneous perineal punch biopsies and transrectal aspiration biopsies for diagnosis of prostate carcinoma. Eur Urol 3: 29–33

    Google Scholar 

  3. Andriole GL, Kavoussi LR, Torrence RJ, Lepor H, Catalano WJ (1988) Transrectal ultrasonography in the diagnosis and staging of carcinoma of the prostate. J Urol 140: 758–760

    PubMed  CAS  Google Scholar 

  4. Bass RB, Barrett DM (1980) Radical retropubic prostatectomy after transurethral resection. J Urol 124: 495–497

    PubMed  Google Scholar 

  5. Beckert R, Klima M, Altwein JE (1989) Chemotherapie des Prostatakarzinoms unter palliativer Zielsetzung? Urology 28: A24

    Google Scholar 

  6. Béland G (1991) Combination of anandrone with orchiectomy in treatment of metastatic prostate cancer. Urology 37 (Suppl): 25–29

    Google Scholar 

  7. Benson RC, Gill GM, Cummings KB (1983) A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate ( Emcyt) for stage D prostatic carcinoma. Sem Oncol 10: 43–45

    Google Scholar 

  8. Blute ML, Zincke H, Farrow GM (1986) Long-term follow-up of young patients with stage A adenocarcinoma of the prostate. J Urol 136: 840–843

    PubMed  CAS  Google Scholar 

  9. Brawer MK (1993) The diagnosis of prostatic carcinoma. Cancer 71 (Suppl): 899–905

    Google Scholar 

  10. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessela RL, Lange PH (1992) Screening for prostatic carcinoma with prostate specific antigen. J Urol 841–845

    Google Scholar 

  11. Byar (1973) The VACURG studies of cancer of the prostate. Cancer 32: 11261130

    Google Scholar 

  12. Campell BW (1958) Total prostatectomy with preliminary ligation of vascular pedicles. J Urol 81: 464–467

    Google Scholar 

  13. Carter HB, Partin AW, Epstein JI et al. (1990) The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer. J Urol 144: 1167–1171

    PubMed  CAS  Google Scholar 

  14. Catalona WJ (1990) Patient selection for, results of, and impact in tumor resection of potency sparing radical prostatectomy. Urol Clin N Am 17: 819826

    Google Scholar 

  15. Catalona WJ, Miller DR, Kavoussi LR (1988) Intermediate-term survival results in clinically understaged prostate cancer patients following radical prostatectomy. J Urol 140: 540–543

    PubMed  CAS  Google Scholar 

  16. Catalona WJ, Smith SD, Ratliff TL et al. (1991) Measurement of prostate specific antigen as a screening test for prostate cancer. N Engl J Med 324: 1156–11611

    Article  PubMed  CAS  Google Scholar 

  17. Catalona WJ, Stein AJ (1982) Accuracy of frozen section detection of lymph node metastases in prostatic carcinoma. J Urol 127: 460

    PubMed  CAS  Google Scholar 

  18. Cooner EH, Mosley BR, Rutherford CL Jr et al. (1990) Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 143: 1146–1154

    PubMed  CAS  Google Scholar 

  19. Crawford (1989) Derzeitige Konzepte in der Behandlung des fortgeschrittenen Prostatakarzinoms. In: Altwein JE, Bartsch G (Hrsg) Therapie des fortgeschrittenen Prostatakarzinoms. PMI, Frankfurt, S 46–54

    Google Scholar 

  20. Crawford ED, Eisenberger MA, McLeod DG et al. (1989) A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 321: 419–424

    Article  PubMed  CAS  Google Scholar 

  21. Dähnert WF, Hamper UM, Eggleston JC et al. (1986) Prostatic evaluation by transrectal sonography with histopathologic correlation: The echopenic appearance of early carcinoma. Radiology 158: 97–102

    PubMed  Google Scholar 

  22. Dalesio 0 (1990) Complete androgen blockade in prostate cancer. Organizing an overview. Cancer 66: 1080–1082

    Google Scholar 

  23. DeKernion JN, Murphy GD, Priore R et al. (1988) Comparison of flutamide and emcyt in hormone-refractory metastatic prostate cancer. Urology 31: 312–317

    Article  CAS  Google Scholar 

  24. Denis L (1992) Maximal androgen blockade: an overview. Cancer

    Google Scholar 

  25. Denis L (1994) Role of maximal androgen blockade in advanced prostate cancer. Prostate-Suppl 5: 17–22

    Article  PubMed  CAS  Google Scholar 

  26. Denis L, Smith P, Carneiro de Moura JL et al. (1991) Total androgen ablation: European experience. Urol Clin N Am 18: 65–73

    CAS  Google Scholar 

  27. Ebert T, Schmitz-Dräger BJ, Bürrig KF et al. (1991) Accuracy of imaging modalities in staging the local extent of prostate cancer. Urol Clin North Am 18: 453–457

    PubMed  CAS  Google Scholar 

  28. Egglestone JC, Walsh PC (1985) Radical prostatectomy with perservation of sexual function: pathological findings in the first 100 cases. J Urol 134: 1146–1148

    Google Scholar 

  29. Elder JS, Jewett HJ, Walsh PC (1982) Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate. J Urol 127: 704

    PubMed  CAS  Google Scholar 

  30. Ellis WJ, Isaacs JT (1985) Effectiveness of complete versus partial androgen withdrawal therapy for the treatment of prostatic cancer as studied in the Dunning R-3327 system of rat prostatic adenocarcinomas. Cancer Res 45: 6041–6050

    PubMed  CAS  Google Scholar 

  31. Flanagan WF, Webster GD, Brown MW et al. (1985) Lumbosacral plexus stretch injury following the use of modified lithotomy position. J Urol 134: 567–568

    PubMed  CAS  Google Scholar 

  32. Franks LM (1974) Biology of the prostate and its tumors. In: Castro JE (ed) The treatment of prostatic hypertrophy and neoplasia. Medical and Technical Publ, London, pp 1–26

    Chapter  Google Scholar 

  33. Frohmüller H, Wirth M, Manseck A, Theiß M (1991) Selektionskriterien für die radikale Prostatektomie unter Berücksichtigung von Langzeitergebnissen. Urologe (A) 30: 394–400

    Google Scholar 

  34. Frohmüller HGW, Wirth MP (1993) Radical prostatectomy for carcinoma of the prostate: Long-term results. Recent results in cancer research, Vol 126

    Google Scholar 

  35. Gibbons RP, Correa RJ Jr, Brannen GE, Mason JT (1984) Total prostatectomy for localized prostatic cancer. J Urol 131: 73–75

    PubMed  CAS  Google Scholar 

  36. Gleason DF (1966) Classification of prostatic carcinomas. Cancer Chemother Rep 50: 125–128

    PubMed  CAS  Google Scholar 

  37. Gleason DF, Mellinger GT, The Veterans Administration Cooperative Urological Research Group (1974) Prediction of prognosis for prostatic adenocarcinoma and combined histological grading and clinical staging. J Urol 11: 58–64

    Google Scholar 

  38. Guinan P, Bush I, Ray V (1980) The accuracy of the rectal examination in the diagnosis of prostatic carcinoma. N Engl J Med 303: 499–503

    Article  PubMed  CAS  Google Scholar 

  39. Hammerer P, Loy V, Dieringer J, Huland H (1992) Prostate cancer in nonurological patients with normal prostates in digital rectal examination. J Urol 147: 833–836

    PubMed  CAS  Google Scholar 

  40. Harada M, Mostofi FK, Corle FK et al. (1977) Preliminary studies of histological prognosis in cancer of the prostate. Cancer Treat Rep 61: 223–225

    PubMed  CAS  Google Scholar 

  41. Hautmann RE, Sauter TW, Wenderoth UK (1994) Radical retropubic prostatectomy: Morbidity and urinary continence in 418 consecutive cases. Supplement to Urologie, Volume 43, Number 2

    Google Scholar 

  42. Helpap B, Böcking A, Dhom G et al. (1985) Klassifikation, histologisches und zytologisches Grading sowie Regressionsgrading des Prostatakarzinoms. Pathologe 6: 3–7

    PubMed  CAS  Google Scholar 

  43. Hermanek P (1993) TNM-Klassifikation maligner Tumoren; UICC, Springer, Heidelberg New York, 4 Auflage

    Google Scholar 

  44. Herr HW (1991) Die Rolle der Strahlentherapie beim lokal begrenzten Prostatakarzinom. Urologe (A) 30: 413–416

    CAS  Google Scholar 

  45. Hölzel D, Altwein JE (1991) Tumoren des Urogenitaltrakts: Klinisch-epidemiologische Fakten. Urologe A 30: 134–138

    Google Scholar 

  46. Hudson HC, Howland RJ Jr (1972) Radical retropubic prostatectomy for cancer of the Prostate. J Urol 108: 944–947

    PubMed  CAS  Google Scholar 

  47. Huggins C, Hodges CV (1941) Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on the normal and on the hyperplastic prostate glands of dogs. Cancer Res. 1: 293–298

    Google Scholar 

  48. Igel TC, Barrett DM, Segura JW et al. (1987) Perioperative and postoperative complications from bilateral pelvic lymphadenectomy and radical retropubic prostatectomy. J Urol 137: 1189–1191

    PubMed  CAS  Google Scholar 

  49. Iversen P, Christensen MG, Friis E et al. (1990a) A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostate. Cancer 66: 1058–1066

    PubMed  CAS  Google Scholar 

  50. Iversen P, Sylvester R et al. (1990b) Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. Cancer 66: 1067–1973

    PubMed  CAS  Google Scholar 

  51. Jewett HJ, Bridge RW, Gray GF Jr, Shelley WM (1968) The palpbale nodule of prostate cancer: results 15 years after radical excision. JAMA 203: 403–406

    Article  PubMed  CAS  Google Scholar 

  52. Jewett HR (1972) Radical perineal prostatectomy in the treatment of carcinoma of the prostate. In: Scott R Jr (ed) Current controversies in urologic management. Saunders, Philadelphia, pp 82–95

    Google Scholar 

  53. Jordan WP, Blackard CE, Byar DP (1977) Reconsideration of orchiectomy in the treatment of advanced prostatic carcinoma. South Med J 70: 1411–1413

    PubMed  Google Scholar 

  54. Kleinschmidt K, Vieweg J, Gottfried HW et al. (1991) Intra-und postoperative Morbidität der radikalen Prostatektomie. Urologe A 30: 387–393

    PubMed  CAS  Google Scholar 

  55. Kopecky AA, Laskowski TZ, Scott R Jr (1970) Radial retropubic prostatectomy in the treatment of prostatic carcinoma. J Urol 103: 641–644

    PubMed  CAS  Google Scholar 

  56. Kozlowski JM, Ellis WJ, Grayhack JT (1991) Advanced prostatic carcinoma. Early versus late endocrine therapy. Urol Clin N Am 18: 15–24

    CAS  Google Scholar 

  57. Kramolowsky EV (1988) The value of testosterone deprivation in stage D1 prostatic carcinoma. J Urol 139: 1242

    PubMed  CAS  Google Scholar 

  58. Labrie F, Dupont A, Bélanger A et al. (1983) New approach in the treatment of prostate cancer: complete instead of only partial withdrawal of androgens. Prostate 4: 579–584

    Article  PubMed  CAS  Google Scholar 

  59. Labrie F, Dupont A, Suburu P, Cusan L, Temblay M, Gomez J-L, Emond J (1992) Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol 846–852

    Google Scholar 

  60. Lange PH, Moon TD, Narayan P et al. (1986) Radiation therapy as adjuvant treatment after radical prostatectomy: patient tolerance and preliminary results. J Urol 136: 45–49

    PubMed  CAS  Google Scholar 

  61. Lawton CA, Won M, Pilepich MV et al. (1991) Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706. Int J Radiation Oncology Biol Phys Vol. 21, pp 935–939

    Article  CAS  Google Scholar 

  62. Lee F, Torp-Pedersen, Littrup PJ et al. (1989) Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination and prostate specific antigen. Radiology 170: 29–32

    PubMed  CAS  Google Scholar 

  63. Lightner DJ, Lange PH, Reddy PK, Moore L (1990) Prostate specific antigen and loal recurrence after radical prostatectomy. J Urol 144: 921–926

    PubMed  CAS  Google Scholar 

  64. Livne PM, Huben RP, Wolf RM et al. (1986) Early complications of combined pelvic lymphadenectomy versus lymphadenectomy alone. Prostate 8: 312–318

    Article  Google Scholar 

  65. Lynch HT, Larsen AL, Magnuson CW et al. (1966) Prostate carcinoma and multiple primary malignancies; study of a family and 109 consecutive prostate cancer patients. Cancer 19: 1891–1897

    Article  PubMed  CAS  Google Scholar 

  66. McCullough DL, McLaughlin AP, Gittes RF (1977) Morbidity of pelvic lymphadenectomy and radical prostatectomy for prostatic cancer. J Urol 117: 206–207

    PubMed  CAS  Google Scholar 

  67. McDuffle RW, Blundon KE (1978) Radical retropubic prostatectomy. 59 cases. J Urol 119: 514–516

    Google Scholar 

  68. McLeod DG, Crawford ED, Blumenstein BA et al. (1992) Controversies in the treatment of metastatic prostate cancer. Cancer 70: 324–328

    Article  PubMed  CAS  Google Scholar 

  69. Meikle AW, Smith JA, West DW (1985) Familial factors affecting prostate cancer risk and plasma sex steroid levels. Prostate 6: 121–128

    Article  PubMed  CAS  Google Scholar 

  70. Mellinger GT, Gleason D, Bailar J (1967) The histology and prognosis of prostatic cancer. J Urol 97: 331–337

    PubMed  CAS  Google Scholar 

  71. Montie JE (1990) Significance and treatment of positive margins or seminal vesical invasion after radical prostatectomy. Urol Clin N Am 17: 803–812

    CAS  Google Scholar 

  72. Morgan WR, Bergstralh EJ, Zincke H (1993) Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer (see comments). Urology 41 (2): 113–120

    Article  PubMed  CAS  Google Scholar 

  73. Mostofi FK, Davis CJ Jr, Sesterhenn IA (1992) Pathology of carcinoma of the prostate. Cancer 70: 235–253

    Article  PubMed  CAS  Google Scholar 

  74. Mostofi FK, Sesterhenn IA, Davis CJ Jr (1976) Problems in pathologic diagnosis of prostatic carcinoma. Semin Oncol 3: 161–169

    PubMed  CAS  Google Scholar 

  75. Mueller RD, Czeglarski G, Bamberg M, Budach V (1987) Nebenwirkungen nach Radiotherapie bis 66 Gy beim Prostatakarzinom. Strahlenther Onkol 163: 755

    Google Scholar 

  76. Murphy GP, Huben RP, Priore R et al. (1986) Results of another trial of chemotherapy with and without hormones in patients with newly diagnosed metastatic prostate cancer. Urology 28: 36–40

    Article  PubMed  CAS  Google Scholar 

  77. Nagel R (1974) Das Prostatakarzinom in den verschiedenen Altersgruppen. Akt Urol 5: 25–32

    Google Scholar 

  78. Nesbit RM, Plumb RT (1946) Prostatic carcinoma: follow-up on 797 patients treated prior to endocrine era and comparison of survival rates between these and patients treated by endocrine therapy. Surgery 20: 263–270

    PubMed  CAS  Google Scholar 

  79. Nichols RT, Barry JM, Hodges CV (1977) The morbidity of radical prostatectomy for multifocal stage I prostatic adenomacarcinoma. J Urol 117: 83–84

    PubMed  CAS  Google Scholar 

  80. Oesterling JE (1991) Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 145: 907–923

    PubMed  CAS  Google Scholar 

  81. Olsson CA (1987) Management of localized adenocarcinoma of the prostate. In: Bruce AW, Trachtenberg J (eds) Adenocarcinoma of the prostate. Springer, London, pp 129–144

    Chapter  Google Scholar 

  82. Parfitt HE, Smith JA, Gliedman JB, Middleton RG (1983) Cancer 51: 2346

    Article  PubMed  Google Scholar 

  83. Parry WL (1983) Radical perineal prostatovesiculectomy. In: Glenn JF (ed) Urologic surgery. Lippincott, Philadelphia, pp 960–967

    Google Scholar 

  84. Paulson DF (1980) The prognostic role of lymphadenectomy in adenocarcinoma of the prostate. Urol Clin N Am 7: 615–629

    CAS  Google Scholar 

  85. Paulson DF, Lin GH, Hinshaw W et al. (1982) Radical prostatectomy versus radiotherapy for stage A2 and stage B adenocarcinoma of the prostate. J Urol 128: 502–505

    PubMed  CAS  Google Scholar 

  86. Paulson DF, Cox EB (1987) Does transurethral resection of the prostate promote metastatic disease? J Urol 138: 90–91

    PubMed  CAS  Google Scholar 

  87. B.J. Schmitz-Dräger, D. Geister und R. Ackermann Pavone-Macaluso M, de Voogt HJ, Viggiano G et al. (1986) Comparison of diethylstilbestrol, cyproterone acetate and medroxy-progesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the EOTC Urological Group. J Urol 136: 624–631

    Google Scholar 

  88. Perez CA, Hanks GE, Leibel SA, Zeitman AI, Fuks Z, Lee WR (1993) Localized carcinoma of the prostate (stages T1B, T1C, T2 and T3). Review of management with external beam radiation therapy. Cancer 72 (11): 3156–3176

    Article  PubMed  CAS  Google Scholar 

  89. Peters PC (1988) Complications of radical prostatectomy and lymphadenectomy. Urol Clin N Am 15: 219–221

    CAS  Google Scholar 

  90. Ray GR, Bagshaw MA, Feiha FS, (1984) External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy. J Urol 132: 926–930

    PubMed  CAS  Google Scholar 

  91. Reiner WG, Walsh PC (1979) An anatomical approach to the surgical management of the dorsal vein and Santorinis plexus during radical retropubic surgery. J Urol 121: 198–200

    PubMed  CAS  Google Scholar 

  92. Ross RK, Paganini-Hill A, Henderson B (1983) The etiology of prostate cancer: what does epidemiology suggest? Prostate 4: 333–344

    Article  PubMed  CAS  Google Scholar 

  93. Saddeler D, Ebert T, Miller S et al. (1994) Altersabhängigke PSA-Normwerte. Ist eine bessere Diskriminierung zwischen Prostatahyperplasie und inzidentellem Prostatakarzinom möglich? Urologe B 34: 165–166

    Google Scholar 

  94. Salo JO, Ranniko S, Makinen J, Lehtonen T (1987) Echogenic structure of prostatic cancer imaged on radical prostatectomy specimens. Prostate 10: 1–9

    Article  PubMed  CAS  Google Scholar 

  95. Schellhammer PF, EI-Mandi AM (1983) Pelvic complications after definitive treatment of prostate cancer by interstitial or external beam radiation. Urology 21: 451–457

    Article  PubMed  CAS  Google Scholar 

  96. Schmidt JD (1984) Cooperative clinical trials of the National Prostatic Cancer Project: Protocol 900. Prostate 5: 387–399

    Article  PubMed  CAS  Google Scholar 

  97. Schmidt JD, Gibbons RP, Murphy GP et al. (1990) Chemohormonal treatment. NPCP protocols 900/1000. In: Murphy G, Koury S, Chatelain C, Denis L (eds) Recent advances in urological cancers — diagnosis and treatment. American Cancer Society, Atlanta/USA, pp 75–83

    Google Scholar 

  98. Schön (1991) Bevölkerungsbezogene Krebsregister in der Bundesrepublik Deutschland. MMV Medizin-Verlag, München

    Google Scholar 

  99. Schulman CC, Sassine AM (1993) Neoadjuvant hormonal deprivation before radical prostatectomy. Eur Urol 24: 450–455

    PubMed  CAS  Google Scholar 

  100. Siddal JK, Cooper EH, Newling DWW, Robinson MRG, Whelan P (1986) Whelan P (1986) An evaluation of the immunochemical measurement of prostatic phosphatase and prostatic specific antigen in carcinoma of the prostate. Eur Urol 12: 123–130

    Google Scholar 

  101. Slack NH (1983) Results of chemotherapy protocols of the USA National Prostatic Cancer Project (NPCP). Clin Oncol 2: 441–459

    Google Scholar 

  102. Smith PH, Suciu S, Robinson MRG et al. (1986) A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostate cancer: final analysis of a phase III trial of the EORTC. J Urol 136: 619–623

    PubMed  CAS  Google Scholar 

  103. Stamey TA, McNeal JE, Freiha FS et al. (1988) Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 139: 1235–1241

    PubMed  CAS  Google Scholar 

  104. Stamey TA, Villers AA, McNeal JA et al. (1990) Positive surgical margins at radical prostatectomy: importance of the apical dissection. J Urol 143: 1166–1173

    PubMed  CAS  Google Scholar 

  105. Stamey TA, Kabalin JN (1989) Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients. J Urol 141: 1166–1173

    Google Scholar 

  106. Tunn UW (1991) Antiandrogene. In: Aktuelle Therapie des Prostatakarzinoms, Ackermann R, Altwein JE, Faul P (Hrsg) Springer, Berlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona Budapest

    Google Scholar 

  107. Tyrell CJ, Altwein JE, Klippel F et al. (1991) A multicenter randomized trial comparing the LH-RH analogue gosereline acetate alone with flutamide in the treatment of advanced prostate cancer. J Urol 146: 1321–1326

    Google Scholar 

  108. Voges GE, McNeal JE, Redwine EA, Freiha FS, Stamey TA (1992) The predictive significance of substaging stage A prostate cancer (Al versus A2) for volume and grade of total cancer in the prostate. J Urol 858–863

    Google Scholar 

  109. Walsh PC, Epstein JI, Lowe FC (1987) Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle. J Urol 138: 823

    PubMed  CAS  Google Scholar 

  110. Walsh PC, Jewett HJ (1980) Radical surgery for prostate cancer. Cancer 45: 1906

    PubMed  CAS  Google Scholar 

  111. Walsh PC, Schlegel PN (1987) Neuroanatomical appraoch to radical cystoprostatectomy with preservation of sexual function. J Urol 138: 1402–1406

    PubMed  Google Scholar 

  112. Wilson JMG (1987) Epidemiology. In: Bruce AW, Trachtenberg J (eds) Adenocarcinoma of the prostate, Springer, Berlin Heidelberg New York, pp 1–28

    Chapter  Google Scholar 

  113. Wirth MP (1990) Wertigkeit der Chemotherapie in der Behandlung des fortgeschrittenen Prostatakarzinoms. In: Frohmüller HGW, Wirth MP (Hrsg) Behandlung des fortgeschrittenen Prostatakarzinoms. Springer, Berlin Heidelberg New York, S 16–21

    Google Scholar 

  114. Wirth MP, Grups J, Frohmüller H (1986) Vergleichende Untersuchungen des prostataspezifischen Antigens und der prostataspezifischen sauren Phosphatase in der Diagnostik und Verlaufskontrolle des Prostata-Carcinoms. Verh Deutsch Ges Urol 4: 75–76

    Google Scholar 

  115. Woolf CM (1960) An investigation of the familiar aspects of carcinoma of the prostate. Cancer 13: 739–743

    Article  PubMed  CAS  Google Scholar 

  116. Zincke H, Bergstralh RJ, Larson-Keller JJ et al. (1992) Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment: evidence for favorable survival in patients with DNA diploid tumors. Cancer 70: 311–323

    Article  PubMed  CAS  Google Scholar 

  117. Zincke H, Fleming TR, Furlow WL, Myers RP, Utz DC (1981) Radical retropubic prostatectomy and pelvic lymphadenectomy for high stage cancer of the prostate. Cancer 47: 1901

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. B. J. Schmitz-Dräger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Geisler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Ackermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Innere Klinik und Poliklinik (Tumorforschung) Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    Siegfried Seeber  & Jochen Schütte  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schmitz-Dräger, B.J., Geisler, D., Ackermann, R. (1995). Prostatakarzinom. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10494-1_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10494-1_41

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-58586-2

  • Online ISBN: 978-3-662-10494-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation